Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Type 2 diabetic patients complete first six-month treatment course with Metformin GR

Jan. 13, 2003

BioSante and Teva to develop hormone therapy product

Jan. 10, 2003

DX-88 granted E.U. orphan drug status for acquired and hereditary angioedema

Jan. 10, 2003

New MCH receptor modulators in early development at Neurogen

Jan. 10, 2003

Axokine granted fast track designation for severe obesity

Jan. 10, 2003

Roche claims novel NPY Y5 antagonists for obesity and other disorders

Jan. 9, 2003

Clinical testing begins for first oral TPO growth factor

Jan. 9, 2003

PDI to commercialize Cellegy's Tostrex in North America

Jan. 9, 2003

Genome Therapeutics and Amgen to develop novel therapeutics for bone diseases

Jan. 9, 2003

Lilly designs novel estrogen receptor modulators

Jan. 8, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...